NASDAQ
Arrowhead Pharmaceuticals, Inc. (ARWR) has a revenue compound annual growth rate of 56.63% over 5 years and 115.61% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.